false
Catalog
Bone and Parathyroid Strategies for Primary Care
Disease State Network Year-in-Review-Bone
Disease State Network Year-in-Review-Bone
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presenters discussed various topics related to bone health, metabolic bone diseases, and parathyroid disorders. They mentioned that they reviewed relevant publications from January 2021 to December 2021, focusing on osteoporosis, vitamin D studies, hypoparathyroidism, hyperparathyroidism, and rare bone disorders. In osteoporosis, they discussed studies on the management and treatment of osteoporosis, the risk factors for fractures, the limitations of serial bone mineral density (BMD) monitoring, and the efficacy of parathyroid hormone therapy. In vitamin D studies, they highlighted the findings of clinical trials on the use of vitamin D supplementation in older adults, muscle function and strength, and the use of metabolomic profiles to assess skeletal health. In hypoparathyroidism, they discussed the use of oral and injectable parathyroid hormone (PTH) for treatment, as well as the potential benefits and challenges associated with these treatments. In hyperparathyroidism, they mentioned the importance of accurate localization strategies, the use of intraoperative PTH monitoring, and the impact of parathyroidectomy on fracture risk and quality of life. Lastly, they briefly touched on rare bone disorders such as acquired PTH resistance, autosomal dominant hypocalcemia type 1, chronic non-bacterial osteomyelitis, and hypophosphatasia. The presenters emphasized the need for ongoing research and tailored treatment approaches in these rare conditions.
Keywords
bone health
metabolic bone diseases
parathyroid disorders
osteoporosis
vitamin D studies
hypoparathyroidism
hyperparathyroidism
rare bone disorders
parathyroid hormone therapy
PTH monitoring
×
Please select your language
1
English